Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis
Objectives: This study aimed to analyse survival in SS-associated pulmonary hypertension (SSc-PH) patients with or without interstitial lung disease (ILD) stratified by PH monotherapy and PH combination therapy, respectively.
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
May 2026
|
| In: |
Rheumatology
Year: 2026, Volume: 65, Fascicolo: 5, Pages: 1-12 |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/keag155 |
| Accesso online: | Verlag, kostenfrei, Volltext: https://doi.org/10.1093/rheumatology/keag155 Verlag, kostenfrei, Volltext: https://academic.oup.com/rheumatology/article/doi/10.1093/rheumatology/keag155/8654708 |
| Note sull'autore: | Marc Schmalzing, Pia Moinzadeh, Jithmi Weliwitage, Joerg Henes, Norbert Blank, Gernot Keysser, Gabriela Riemekasten, Ulf Mueller-Ladner, Margitta Worm, Aaron Juche, Alexander Kreuter, Jan Ehrchen, Laura Susok, Claudia Guenther, Gabriele Zeidler, Ilona Jandova, Tim Schmeiser, Christiane Pfeiffer, Ina Koetter, Annette Alberding, Joerg H.W. Distler, Nicolas Hunzelmann; DNSS Study Group |
| Riassunto: | Objectives: This study aimed to analyse survival in SS-associated pulmonary hypertension (SSc-PH) patients with or without interstitial lung disease (ILD) stratified by PH monotherapy and PH combination therapy, respectively. |
|---|---|
| Descrizione del documento: | Veröffentlicht: 15 April 2026 Gesehen am 23.07.2026 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/keag155 |